Effects of Pitavastatin on Insulin Sensitivity and Liver Fat
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2017
At a glance
- Drugs Pitavastatin (Primary)
- Indications Fatty liver; Obesity
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 19 Feb 2015 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018 as reported by ClinicalTrials.gov.
- 19 Feb 2015 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2018 as reported by ClinicalTrials.gov.